Back to search

Article

Immunogenic cell death signatures derived from on-treatment tumor specimens for predicting immune checkpoint blockade therapy response and prognosis in metastatic melanoma

2024-08-17

Abstract excerpt

<title>Abstract</title> <p>Melanoma is a highly malignant form of skin cancer that typically originates from abnormal melanocytes. Despite significant advances in treating metastatic melanoma with immune checkpoint blockade (ICB) therapy, a substantial number of patients do not respond to this treatment and face risks of recurrence and metastasis. This study collected data from multiple datasets, including cohort...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
32afdd77-af26-5fd6-9401-0e844db865cc
DOI
10.21203/rs.3.rs-4750701/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Immunogenic cell death signatures derived from on-treatment tumor specimens for predicting immune checkpoint blockade therapy response and prognosis in metastatic melanomaDOI 10.21203/rs.3.rs-4750701/v1
Ligand-receptor pair-based signature score Derived from On-treatment Tumor Specimens Predicts Immune Checkpoint Blockade Response in Metastatic MelanomaSemantic proximity
Prognostic Modeling of Patients with Metastatic Melanoma Based on Tumor Immune Microenvironment CharacteristicsSemantic proximity
An Immunogenic Cell Death-Related Gene Signature Reflects Immune Landscape and Predicts Prognosis in Melanoma Independently of BRAF V600E Status.Semantic proximity
Establishment and Evaluation of Immune Checkpoint Inhibitor Treatment Response Model Based on Gene Expression ValueSemantic proximity
Strategies for Improving the Performance of Prediction Models for Response to Immune Checkpoint Blockade Therapy in CancerSemantic proximity
Immune Cell as a Promising Biomarker in the Diagnosis and Prognosis of Cutaneous Melanoma by Using Machine LearningSemantic proximity
Integrating tumor and immune cell transcriptomics to predict immune checkpoint inhibitor primary resistance in metastatic cutaneous melanomaSemantic proximity
Construction of immune scores to predict patient prognosis and response of anti-PD1 treatment in stage III-IV melanomaSemantic proximity
Identification of an Immune-Related Prognostic Signature Associated with Immune Infiltration in MelanomaSemantic proximity
Systematic evaluation of the predictive gene expression signatures of immune checkpoint inhibitors in metastatic melanomaSemantic proximity
Evaluation of immunological characteristics and prognosis in melanoma patients using an endoplasmic reticulum stress-associated signature based on bioinformatic analysisSemantic proximity
Development and Validation of An Immune-Related Gene Pair Signature in Skin Cutaneous MelanomaSemantic proximity
Select a neighboring publication to make it the new centre.